Group Exercise in Cancer Patients Under Active Treatment: Feasibility Pilot Study.

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

September 30, 2027

Conditions

Neoplastic Disease

Interventions

PROCEDURE

exercise programme for group with ECOG 0-1

exercise programme for group with ECOG 2

PROCEDURE

exercise programme for ECOG 2 group

this intervention shall be proportionated to the ECOG status of the group

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT06825429 - Group Exercise in Cancer Patients Under Active Treatment: Feasibility Pilot Study. | Biotech Hunter | Biotech Hunter